BioSpace News Archive

Business

Zevra Therapeutics to Report 2023 Fourth Quarter and Full Year Financial Results on March 28, 2024

Zevra Therapeutics, Inc. today announced that it will host a conference call and live audio webcast on Thursday, March 28, 2024, at 4:30 p.m. ET, to review its corporate and financial results for the fourth quarter and full year 2023.

March 18, 2024
·
2 min read
Drug Development

Intellia Therapeutics Announces First Patient Dosed in the Phase 3 MAGNITUDE Study of NTLA-2001 as a Single-Dose CRISPR-Based Treatment for Transthyretin Amyloidosis with Cardiomyopathy

Intellia Therapeutics, Inc. today announced the first patient dosed in the global pivotal, Phase 3 MAGNITUDE trial of NTLA-2001.

March 18, 2024
·
7 min read
Cybin to Present at Public Ventures Discovery Day on March 19th in Dallas

Cybin Inc today announced participation in the upcoming Public Ventures Discovery Day on March 19, 2024 in Dallas, TX.

March 18, 2024
·
2 min read
Genetown

bluebird bio Secures up to $175 Million Debt Financing with Hercules Capital

bluebird bio, Inc. (NASDAQ: BLUE) (“bluebird bio” or the “Company”) today announced that it has entered into a $175 million five-year, term loan facility with Hercules Capital, Inc.

March 18, 2024
·
6 min read
Business

Lineage Cell Therapeutics and the Christopher & Dana Reeve Foundation Proudly Announce the 2nd Annual Spinal Cord Injury Investor Symposium

Lineage Cell Therapeutics and the Christopher & Dana Reeve Foundation Proudly Announce the 2nd Annual Spinal Cord Injury Investor Symposium.

March 18, 2024
·
9 min read
Business

Nanox to Report Fourth Quarter and Fiscal Year 2023 Financial Results on April 1, 2024

NANO-X IMAGING LTD today announced that it will report its financial results for the quarter and fiscal year ended December 31, 2023, before market open on Monday, April 1, 2024.

March 18, 2024
·
1 min read
Lunit Expands Presence in Europe: to Deliver AI-powered Cancer Screening Solution to France and Portugal

Lunit, a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, announces two commercial deals that signal its expansion in Europe.

March 18, 2024
·
3 min read
BioCapital

American Association for Anatomy Publishes New Guidelines for The Ethical Management of Human Remains

The American Association for Anatomy released the whitepaper “Recommendations for the Management of Legacy Anatomical Collections” to provide ethical guidance on the treatment of human remains in public and private institutions, many of which were collected before today’s standard of informed consent.

March 18, 2024
·
2 min read
Business

GRAIL Announces Novel Risk Classification Test to Be Used in Lung Cancer Study

GRAIL, LLC, a healthcare company whose mission is to detect cancer early when it can be cured, announced today that participants from Japan, via a collaboration with AstraZeneca (LSE/STO/Nasdaq:AZN), will have their samples tested using GRAIL’s novel risk classification test on its Methylation Platform.

March 18, 2024
·
2 min read
Business

Nodexus Names William Rhodes Executive Chairman of the Board

Nodexus Inc. today announced that William (Bill) Rhodes has been named Executive Chairman of the company’s Board of Directors.

March 18, 2024
·
2 min read